Skip to main content

Articles

Page 38 of 335

  1. The immunological checkpoint known as Inducible T Cell Costimulatory Factor (ICOS, Cluster of Differentiation, CD278) is activated and expressed on T cells. Both somatic cells and antigen-presenting cells expr...

    Authors: Xiashuang Zhao, Yongfeng Wang, Xianglai Jiang, Bangqian Mo, Chenyu Wang, Mingzheng Tang, Yao Rong, Guiqian Zhang, Ming Hu and Hui Cai
    Citation: BMC Cancer 2023 23:194
  2. Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal...

    Authors: Yizhen Fu, Zhenyun Yang, Zili Hu, Zhoutian Yang, Jinbin Chen, Juncheng Wang, Zhongguo Zhou, Li Xu, Minshan Chen and Yaojun Zhang
    Citation: BMC Cancer 2023 23:193
  3. Authors: Cengiz Karacin, Berna Oksuzoglu, Ayşe Demirci, Merve Keskinkılıç, Naziyet Köse Baytemür, Funda Yılmaz, Oğuzhan Selvi, Dilek Erdem, Esin Avşar, Nail Paksoy, Necla Demir, Sema Sezgin Göksu, Sema Türker, Ertuğrul Bayram, Abdüssamet Çelebi, Hatice Yılmaz…
    Citation: BMC Cancer 2023 23:192

    The original article was published in BMC Cancer 2023 23:136

  4. Patients with V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E-mutated advanced colorectal cancer (CRC) have a poor prognosis, and treatment options that can improve outcome are still under investig...

    Authors: Qianhao Meng, Jian Zhao, Yuanyuan Yu, Ke Wang, Jing Ren, Chang Xu, Yusheng Wang and Guangyu Wang
    Citation: BMC Cancer 2023 23:191
  5. Pancreatic adenocarcinoma (PDAC) persists as a malignancy with high morbidity and mortality that can benefit from new means to characterize and detect these tumors, such as radiogenomics. In order to address t...

    Authors: Neema Jamshidi, Jayasuriya Senthilvelan, David W. Dawson, Timothy R. Donahue and Michael D. Kuo
    Citation: BMC Cancer 2023 23:189
  6. Inflammation is implicated in tumorigenesis and has been reported as an important prognostic factor in cancers. In this study, we aimed to develop and validate a novel inflammation score (IFS) system based on ...

    Authors: Jun Fu, Qinjunjie Chen, Zisen Lai, Kongying Lin, Guoxu Fang, Zongren Ding, Yuzhen Gao and Yongyi Zeng
    Citation: BMC Cancer 2023 23:188
  7. Colposcopy is an important tool in diagnosing cervical cancer, and the International Federation of Cervical Pathology and Colposcopy (IFCPC) issued the latest version of the guidelines in 2011. This study aims...

    Authors: Dongxu Qin, Anying Bai, Peng Xue, Samuel Seery, Jiaxu Wang, Maria Jose Gonzalez Mendez, Qing Li, Yu Jiang and Youlin Qiao
    Citation: BMC Cancer 2023 23:187
  8. Gastric cancer (GC), gastroesophageal junction cancer (GEJC), and esophageal adenocarcinoma (EAC), together, are leading causes of cancer deaths worldwide. Patient health-related quality of life (HRQoL) and we...

    Authors: Hong Xiao, David Bertwistle, Keerun Khela, Chloe Middleton-Dalby and Jennifer Hall
    Citation: BMC Cancer 2023 23:186
  9. Glioblastoma, the most common primary malignant brain tumour in adults, is a highly vascular tumour characterised by abnormal angiogenesis. Additional mechanisms of tumour vascularisation have also been report...

    Authors: Kelsey Maddison, Nikola A. Bowden, Moira C. Graves and Paul A. Tooney
    Citation: BMC Cancer 2023 23:185
  10. Double-hit or Triple-hit lymphoma (DHL/THL) is a subset of high-grade B cell lymphoma harboring rearrangements of MYC and BCL2 and/or BCL6, and usually associate with aggressive profile, while current therapies t...

    Authors: Tao Lei, Gongqiang Wu, Yongjin Xu, Weihao Zhuang, Jialiang Lu, Shuiyun Han, Yuxin Zhuang, Xiaowu Dong and Haiyan Yang
    Citation: BMC Cancer 2023 23:184
  11. Breast cancer survivors face long-term sequelae compared to the general population, suggesting altered metabolic profiles after breast cancer. We used metabolomics approaches to investigate the metabolic diffe...

    Authors: Jiajun Luo, Muhammad G. Kibriya, Hui Chen, Karen Kim, Habibul Ahsan, Olufunmilayo I. Olopade, Christopher S. Olopade, Briseis Aschebrook-Kilfoy and Dezheng Huo
    Citation: BMC Cancer 2023 23:183
  12. An increasing number of trials indicate that treatment outcomes in cancer patients with metastatic disease are improved when targeted treatments are matched with druggable genomic alterations in individual pat...

    Authors: Tina Kringelbach, Martin Højgaard, Kristoffer Rohrberg, Iben Spanggaard, Britt Elmedal Laursen, Morten Ladekarl, Charlotte Aaquist Haslund, Laurine Harsløf, Laila Belcaid, Julie Gehl, Lise Søndergaard, Rikke Løvendahl Eefsen, Karin Holmskov Hansen, Annette Raskov Kodahl, Lars Henrik Jensen, Marianne Ingerslev Holt…
    Citation: BMC Cancer 2023 23:182
  13. Advanced gastro-oesophageal cancer (AGOC) carries a poor prognosis. No standard of care treatment options are available after first and second-line therapies. Regorafenib is an oral multi-targeted tyrosine kin...

    Authors: Lyn Ley Lam, Nick Pavlakis, Kohei Shitara, Katrin M. Sjoquist, Andrew J. Martin, Sonia Yip, Yoon-Koo Kang, Yung-Jue Bang, Li-Tzong Chen, Markus Moehler, Tanios Bekaii-Saab, Thierry Alcindor, Christopher J. O’Callaghan, Niall C. Tebbutt, Wendy Hague, Howard Chan…
    Citation: BMC Cancer 2023 23:180
  14. Are twofold: 1) to estimate the relationship between obesity (BMI ≥30) and the prevalence of melanoma in different US states and 2) to examine the possibility of defining a new risk group. This might enhance t...

    Authors: Yuval Arbel, Yifat Arbel, Amichai Kerner and Miryam Kerner
    Citation: BMC Cancer 2023 23:178
  15. Fluorouracil, leucovorin (5FU/LV), and nanoliposomal-irinotecan (nal-IRI) combination therapy has been established as the second-line treatment for advanced pancreatic ductal adenocarcinoma. Oxaliplatin with 5...

    Authors: Satoshi Kobayashi, Shun Tezuka, Yui Yamachika, Shotaro Tsunoda, Shuhei Nagashima, Yuichiro Tozuka, Taito Fukushima, Manabu Morimoto, Makoto Ueno, Junji Furuse and Shin Maeda
    Citation: BMC Cancer 2023 23:177
  16. Hepatocellular carcinoma (HCC) is associated with a high occurrence, mortality, and poor prognosis. MLX interacting protein like (MLXIPL) is an important regulator of glucolipid metabolism and is involved in t...

    Authors: Xiaowei Chang, Chang Tian, Yuanyuan Jia, Yu Cai and Pu Yan
    Citation: BMC Cancer 2023 23:176
  17. Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death, so we should be concerned and look for effective/less-harmful treatments than chemotherapeutics already clinically in applic...

    Authors: Rana R. El Sadda, Zahraa R. Elshahawy and Entsar A. Saad
    Citation: BMC Cancer 2023 23:175
  18. Gliomas are the most common brain tumours with the high-grade glioblastoma representing the most aggressive and lethal form. Currently, there is a lack of specific glioma biomarkers that would aid tumour subty...

    Authors: Agathe Quesnel, Nathan Coles, Claudio Angione, Priyanka Dey, Tuomo M. Polvikoski, Tiago F. Outeiro, Meez Islam, Ahmad A. Khundakar and Panagiota S. Filippou
    Citation: BMC Cancer 2023 23:174
  19. Novel antibody‒drug conjugates (ADC) have shown great efficacy in HER2-low advanced breast cancer. However, the clinical features of HER2-low disease still need to be clarified. The current study aims to evalu...

    Authors: Qin Shi, Jing Yu, Deyue Liu, Fang Ren, Jiayi Wu and Kunwei Shen
    Citation: BMC Cancer 2023 23:173
  20. Dishevelled paralogs (DVL1, 2, 3) are key mediators of Wnt pathway playing a role in constitutive oncogenic signaling influencing the tumor microenvironment. While previous studies showed correlation of β-cate...

    Authors: Fahmida Rasha, Geetha Priya Boligala, Mingxiao V. Yang, Dalia Martinez-Marin, Isabel Castro-Piedras, Kathryn Furr, Annie Snitman, Sonia Y. Khan, Luis Brandi, Maribel Castro, Hafiz Khan, Nusrat Jahan, Sharilyn Almodovar, Michael W. Melkus, Kevin Pruitt and Rakhshanda Layeequr Rahman
    Citation: BMC Cancer 2023 23:172
  21. Breast cancer is one of the most prevalent malignant diseases in women. The development of dose dense chemotherapy regimens has improved clinical outcomes but has been associated with increased hematological t...

    Authors: Ahmed Rashed, Orla M Fitzpatrick, David J Easty, Zac Coyne, Dearbhaile Collins, Victoria Mallet, Maciej Milewski, Keith Egan, Oscar S Breathnach, Liam Grogan, Bryan T Hennessy and Patrick G Morris
    Citation: BMC Cancer 2023 23:171
  22. Several clear cell renal cell carcinoma (ccRCC) cases harbour fibroblast growth factor receptor 4 (FGFR4) gene copy number (CN) gains. In this study, we investigated the functional contribution of FGFR4 CN amplif...

    Authors: Takafumi Narisawa, Sei Naito, Hiromi Ito, Osamu Ichiyanagi, Toshihiko Sakurai, Tomoyuki Kato and Norihiko Tsuchiya
    Citation: BMC Cancer 2023 23:170
  23. Nasopharyngeal carcinoma (NPC), especially the nonkeratinizing type, is a malignant tumor primarily occurring in southern China and Southeast Asia. Chemotherapy (CT) and combined radiotherapy (RT) is used to t...

    Authors: Feng Ling, Shengen Xu, Xiaochen Li, Xingwang Sun and Wenbo Long
    Citation: BMC Cancer 2023 23:169

    The Correction to this article has been published in BMC Cancer 2023 23:190

  24. DNA methylation is an essential factor in the progression of cervical intraepithelial neoplasia (CIN) to cervical cancer. The aim was to investigate the diagnostic value provided by methylation biomarkers of s...

    Authors: Liye Shi, Xue Yang, Ling He, Chunying Zheng, Zhen Ren, Juweria Abdisamad Warsame, Suye Suye, Lei Yan, Haiyi Cai, Xiao Xiao and Chun Fu
    Citation: BMC Cancer 2023 23:168
  25. A Wilms’ tumor 1 (WT1) oral vaccine, Bifidobacterium longum (B. longum) 420, in which the bacterium is used as a vector for WT1 protein, triggers immune responses through cellular immunity consisting of cytotoxic...

    Authors: Hikaru Minagawa, Yoshiko Hashii, Hiroko Nakajima, Fumihiro Fujiki, Soyoko Morimoto, Jun Nakata, Toshiro Shirakawa, Takane Katayama, Akihiro Tsuboi and Keiichi Ozono
    Citation: BMC Cancer 2023 23:167
  26. Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of melanoma and other cancers. However, no reliable biomarker of survival or response has entered the clinic to identify those patients wit...

    Authors: Alessia Visconti, Niccolò Rossi, Helena Deriš, Karla A Lee, Maja Hanić, Irena Trbojević-Akmačić, Andrew M. Thomas, Laura A. Bolte, Johannes R. Björk, Jahlisa S. Hooiveld-Noeken, Ruth Board, Mark Harland, Julia Newton-Bishop, Mark Harries, Joseph J. Sacco, Paul Lorigan…
    Citation: BMC Cancer 2023 23:166
  27. To identify the main risk factors for metachronous metastatic nasopharyngeal carcinoma (NPC) in different periods after radiotherapy and estimate the weight of various factors in the early or late metachronous...

    Authors: Zhaodong Fei, Huiling Hong, Ting Xu, Yiying Xu, Jiawei Chen, Xiufang Qiu, Jianming Ding, Ye Feng, Chaoxiong Huang, Li Li, Mengying Li and Chuanben Chen
    Citation: BMC Cancer 2023 23:165
  28. High-throughput screening (HTS) of small molecule drug libraries has greatly facilitated the discovery of new cancer drugs. However, most phenotypic screening platforms used in the field of oncology are based ...

    Authors: Tove Selvin, Malin Berglund, Lena Lenhammar, Malin Jarvius, Peter Nygren, Mårten Fryknäs, Rolf Larsson and Claes R Andersson
    Citation: BMC Cancer 2023 23:164
  29. Colposcopic examination with biopsy is the standard procedure for referrals with abnormal cervical cancer screening results; however, the decision to biopsy is controvertible. Having a predictive model may help t...

    Authors: Peng Xue, Samuel Seery, Sumeng Wang, Yu Jiang and Youlin Qiao
    Citation: BMC Cancer 2023 23:163
  30. Oral squamous cell carcinoma (OSCC) is a common malignant tumor associated with poor prognosis. MicroRNAs (miRNAs) play crucial regulatory roles in the cancer development. However, the role of miRNAs in OSCC d...

    Authors: Guoqiang Xu, Yiyan Yang, Junting Yang, Lanfei Xiao, Xiaotang Wang, Litao Qin, Jiping Gao, Ruijing Xuan, Xiaofen Wu, Zhaoyang Chen, Rui Sun and Guohua Song
    Citation: BMC Cancer 2023 23:162
  31. The classification of thymomas is based on the morphology of epithelial tumor cells and the proportion of lymphocytes. Type A thymomas are composed of the spindle or oval tumor epithelial cells. Tumor cells of...

    Authors: Huiyang Li, Bo Ren, Shili Yu, Hongwen Gao and Ping-Li Sun
    Citation: BMC Cancer 2023 23:161
  32. Clear cell renal cell carcinoma (ccRCC) is common in urinary system tumors. Cuproptosis is a non-apoptotic cell death pathway. Copper binds to fatty acylated mitochondrial proteins and activates various forms ...

    Authors: Junlin Shen, Linhui Wang and Jianbin Bi
    Citation: BMC Cancer 2023 23:160
  33. Diet may impact important risk factors for endometrial cancer such as obesity and inflammation. However, evidence on the role of specific dietary factors is limited. We investigated associations between dietar...

    Authors: S. G. Yammine, I. Huybrechts, C. Biessy, L. Dossus, S. Panico, M. J. Sánchez, V. Benetou, R. Turzanski-Fortner, V. Katzke, A. Idahl, G. Skeie, K. Standahl Olsen, A. Tjønneland, J. Halkjaer, S. Colorado-Yohar, A. K. Heath…
    Citation: BMC Cancer 2023 23:159
  34. Chronic inflammation is a hallmark of cancer, and it can be stimulated by many factors. Substance P (SP), through binding to neurokinin 1 receptor (NK1R), and pyruvate kinase M2 (PKM2) play critical roles in c...

    Authors: Maha S. Al-Keilani, Roba Bdeir, Rana I. Elstaty and Mohammad A. Alqudah
    Citation: BMC Cancer 2023 23:158
  35. A recent theory supports that high-grade serous epithelial ovarian cancer derives from the fimbrial end of the fallopian tube and during the last decade, a few studies have examined the fallopian tube cytology...

    Authors: Sofia Lekka, Victoria Psomiadou, Theodoros Panoskaltsis, Eleni Tsouma, Natasa Novkovic, Helen Trihia, Olympia Tzaida, Dimitrios Korfias, Panagiotis Giannakas, Christos Iavazzo, Panagiotis Vakas, Nikolaos Vlahos and George Vorgias
    Citation: BMC Cancer 2023 23:157
  36. Diet, alcohol, cigarette smoking, physical inactivity, and body mass index have been studied as risk factors for renal cell cancer (RCC). The joint effects of these lifestyle factors, captured as Healthy Lifes...

    Authors: Romain Meer, Jeroen van de Pol, Piet A. van den Brandt and Leo J. Schouten
    Citation: BMC Cancer 2023 23:156
  37. Galectin-3 (Gal-3), the only chimeric β-galactosides-binding lectin, consists of Gal-3N (N-terminal regulatory peptide) and Gal-3C (C-terminal carbohydrate-recognition domain). Interestingly, Gal-3C could spe...

    Authors: Xiaoge Gao, Pin Jiang, Xiaohuan Wei, Wei Zhang, Jiwei Zheng, Shishuo Sun, Hong Yao, Xiangye Liu and Qing Zhang
    Citation: BMC Cancer 2023 23:154

    The Correction to this article has been published in BMC Cancer 2023 23:359

  38. Glucose and glutamine are the main energy sources for tumor cells. Whether glycolysis and glutaminolysis play a critical role in driving the molecular subtypes of lung adenocarcinoma (LUAD) is unknown. This st...

    Authors: Jinjin Zhang, Xiaopeng Wang, Congkuan Song and Qi Li
    Citation: BMC Cancer 2023 23:152
  39. This retrospective cohort study examined the impact of tetracyclines (TCs) and proton pump inhibitors (PPIs) alone or in combination on the efficacy of epidermal growth factor receptor tyrosine kinase inhibito...

    Authors: Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, Yu-Hung Kuo and Mann-Jen Hour
    Citation: BMC Cancer 2023 23:151
  40. As a consequence of effective treatment procedures, the number of long-term survivors of colorectal cancer is ever increasing. Adopting the method of a previous study on breast cancer patients, the goal of the...

    Authors: Vinzenz Völkel, Brunhilde Steinger, Michael Koller, Monika Klinkhammer-Schalke and Patricia Lindberg-Scharf
    Citation: BMC Cancer 2023 23:149
  41. Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of tumors with a broad range of local and systemic treatment options. Still a lack of data regarding treatment sequences exists...

    Authors: Rahel Stiefel, Kuno Lehmann, Thomas Winder and Alexander R. Siebenhüner
    Citation: BMC Cancer 2023 23:148
  42. The protein kinase C (PKC) family of serine/threonine kinases contains more than ten isozymes that are involved in multiple signaling pathways, including cell cycle regulation and carcinogenesis. The PKCε isoz...

    Authors: Areeba Rehman, Maria Shabbir, Yasmin Badshah, Khushbukhat Khan, Janeen H. Trembley, Naeem Mahmood Ashraf, Tayyaba Afsar, Ali Almajwal, Nawaf W. Alruwaili, Ali Alshamari, Tariq Nahar Alanezi and Suhail Razak
    Citation: BMC Cancer 2023 23:147
  43. TAP1 is an immunomodulation-related protein that plays different roles in various malignancies. This study investigated the transcriptional expression profile of TAP1 in uveal melanoma (UVM), revealed its pote...

    Authors: Ru Zhu, Yu-Ting Chen, Bo-Wen Wang, Ya-Yan You, Xing-Hua Wang, Hua-Tao Xie, Fa-Gang Jiang and Ming-Chang Zhang
    Citation: BMC Cancer 2023 23:146

Featured videos

View featured videos from across the BMC-series journals